Related Experiment Video
Updated: Jan 22, 2026

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
Hypertriglyceridemic waist and subclinical atherosclerosis: a systematic review and meta-analysis
Wei Xiong1, Hua Fan2, Yao You3,4,5,6
1Department of Science and Education, The First People's Hospital of Jiande, Hangzhou, China.
Insights
Hypertriglyceridemic waist (HTGW) is a cost-effective indicator for detecting subclinical atherosclerosis. This non-invasive test can help identify individuals at risk for cardiovascular events, enabling earlier intervention.
Area of Science:
- Cardiovascular Medicine
- Metabolic Syndrome
- Diagnostic Testing
Background:
- Atherosclerosis is a chronic inflammatory disease leading to cardiovascular events.
- Subclinical atherosclerosis precedes symptomatic disease.
- Hypertriglyceridemic waist (HTGW) is a proposed inexpensive, non-invasive marker.
Purpose of the Study:
- To evaluate the Hypertriglyceridemic waist (HTGW) phenotype as a screening tool for subclinical atherosclerosis.
Main Methods:
- Systematic literature search across seven databases.
- Meta-analysis of six studies assessing HTGW and subclinical atherosclerosis.
- Carotid intima-media thickness and plaque used as surrogate markers.
Main Results:
- Six studies met inclusion criteria.
- HTGW was significantly associated with subclinical atherosclerosis (OR = 2.39, 95% CI = 1.63–3.51).
Conclusions:
- The Hypertriglyceridemic waist (HTGW) phenotype is a viable, inexpensive screening method for subclinical atherosclerosis.
- This finding supports HTGW as an effective tool for early cardiovascular risk assessment.
Background:
Atherosclerosis is a chronic, progressive inflammatory disease with a long asymptomatic period. Disease progression can eventually lead to acute cardiovascular events, such as myocardial infarction, unstable angina, and sudden cardiac death. Hypertriglyceridemic waist (HTGW) has received much attention recently as a cheap and non-invasive test. The purpose of our study was to explore whether the HTGW phenotype could be used as an effective test for subclinical atherosclerosis.
Methods:
We screened seven databases (PubMed, Cochrane Library, EMBASE, CNKI, WANFANG, CBM, and Web of Science) using both free terms and MeSH terms. Six published studies which evaluate the connection between HTGW and subclinical atherosclerosis were selected. Total carotid intima-media thickness (IMT) and carotid plaque are surrogate markers of subclinical atherosclerosis and predictors of cardiovascular events. Demographic and clinical data, data on HTGW and markers associated with subclinical atherosclerosis, along with odds ratios (OR), relative risks (RR), and hazard ratios (HR) with 95% confidence intervals were extracted. Data were then integrated using Stata 16.
Results:
A total of six studies conformed to inclusion criteria and revealed that HTGW is associated with subclinical atherosclerosis (OR = 2.39, 95% CI = 1.63-3.51).
Conclusion:
Available evidence supports the notion that HTGW can be an effective and inexpensive means of testing for atherosclerosis.
More Related Videos
08:36Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
06:26Meta-analysis of Voxel-Based Neuroimaging Studies using Seed-based d Mapping with Permutation of Subject Images SDM-PSI
Published on: November 27, 2019
Related Concept Videos
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Atherosclerosis III: Management
Atherosclerosis I: Introduction
Random and Systematic Errors
Directing Effect of Substituents: meta-Directing Groups